Our organisation

> Consultez la version française

Two bodies are tasked with ANSM’s governance: a Management Board, and a Scientific Board.

In addition, since 2019, the Agency’s policy of openness to civil society has resulted in healthcare system users being systematically involved in our consultative bodies of expertise. We are convinced of the need to work alongside patients and healthcare professionals to ensure that our action addresses the challenges that they face on a daily basis.

For this reason, our decisions are based on the opinions of several consultative committees, in which the expertise of representatives of civil society, their perspective, and their vision of the health sector allow objective and informed decision-making.

The board of medical, pharmaceutical and patient advisers

Consultez la version française

All members of our advisory bodies are subject to the ANSM's ethical rules. The composition of these committees, the agendas and meeting minutes are published on the ANSM's website. The ANSM’s policy of openness to society as a whole is also reflected in the live broadcasting of filmed public hearings on the agency's YouTube channel.

Attentive to the concerns of patients and healthcare professionals on the ground, the mandate of the Board of Advisers is to provide support and advice to divisions and assessors.

The Board is composed of:

medical advisers with clinical or academic experience who are able to mobilise and inform a network of practitioners;
a pharmaceutical adviser who reinforces in-house pharmaceutical expertise, supporting the divisions;
a patient adviser providing the patient's point of view and serving as an interface with a patient network.

The board members contribute to the development of the Agency’s public health policy. Through their feedback, they help to define the annual programme and its operational implementation. They may take part in standing and temporary scientific committees, and may be consulted in the context of high-risk situations, as well as for practice-related issues in the context of the assessment of submissions.

Composition of the Board of medical, pharmaceutical and patient advisors

Trystan BACON - Medical adviser, general medicine
Pascale DAYNES - Patient adviser
Christophe DECOENE - Medical adviser, cardiology, anaesthesiology
Patrick FEUGIER - Medical adviser
Roseline MAZET - Hospital pharmaceutical adviser
Valentine RUSTE - Scientific medical adviser (oncology)
Thierry VIAL - Medical adviser

Our organisation

Our bodies

The board of medical, pharmaceutical and patient advisers

Composition of the Board of medical, pharmaceutical and patient advisors